Pharmacy
Home Pharmacy
Venetoclax Monotherapy Active in AML With Adverse Features
Overall response rate 19%; additional 19% have antileukemic activity without meeting IWG criteria
CDC: Benzodiazepines Prescribed at 27 Office Visits Per 100 Adults
Overlapping opioid Rx involved in about one-third of visits at which benzodiazepines were prescribed
Glaucoma Surgery Risk Up With 7+ Injections of Bevacizumab
Patients who received four to six injections had a nonsignificantly increased risk of glaucoma surgery
FDA Approves Adlyxin for Type 2 Diabetes Mellitus
Once-daily injection to improve glycemic control, along with diet and exercise
Hep B, C Could Be Eliminated As Public Health Threats by 2030
Tools exist to prevent hepatitis B and C mortality, including vaccination and treatment
Genetic Variations Could Hold Keys to Rheumatoid Arthritis Care
New research reveals clues to disease severity, potential outcomes
Skyrizi Approved for Psoriatic Arthritis
Approval based on two Phase 3 trials showing more than 50 percent of patients receiving Skyrizi achieved ACR20 response at 24 weeks
Contraindication to Antiplatelet Rx for ~18 Percent With PCI
Six percent of these patients receive antiplatelets; no increased mortality with contraindicated med use
ASCO Calls for Cancer Trials to Include More Seniors
Older adults react differently to treatment, oncology group notes
Review Explores Challenges of Ocular Antioxidants for Cataracts
Prospects for future research include the use of nanotechnology to deliver antioxidants
